Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Horne

Showing results (181-190 of 499) with videos related to

Pageof 50
Sort By:
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Hypofractionated stereotactic body radiation therapy for elderly patients with stage IIB-IV nonsmall cell lung cancer who are ineligible for or refuse other treatment modalitiesSana D Karam, Zachary D Horne, Robert L Hong, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Establishing a histology-specific biologically effective dose threshold for lung stereotactic ablative radiotherapy (SABR): Is ≥100 Gy<sub>10</sub> enough?Stephen Abel, Shaakir Hasan, Vivek Verma, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 9, 2020
The Summit Score Stratifies Mortality and Morbidity in Chronic Obstructive Pulmonary DiseaseBenjamin D Horne, Matthew J Hegewald, Courtney Crim, et al.
Journal of Psychosomatic Research|July 14, 2010
Antilipidemic adherence post-coronary artery disease diagnosis among those with and without an ICD-9 diagnosis of depressionHeidi T May, Xiaoming Sheng, A Peter Catinella, et al.
Ecology and Evolution|September 20, 2019
Last exit before the brink: Conservation genomics of the Cambodian population of the critically endangered southern river terrapinF Gözde Çilingir, Adeline Seah, Brian D Horne, et al.
Radiation Oncology (London, England)|July 12, 2013
Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancerSana D Karam, Zachary D Horne, Robert L Hong, et al.
Radiation Oncology Journal|January 12, 2019
Trends in intensity-modulated radiation therapy use for rectal cancer in the neoadjuvant setting: a National Cancer Database analysisRodney E Wegner, Stephen Abel, Richard J White, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
The role of adjuvant therapy for atypical bronchopulmonary carcinoidsRodney E Wegner, Stephen Abel, Shaakir Hasan, et al.
The Annals of Thoracic Surgery|December 18, 2019
Drivers of 30- and 90-day Postoperative Death After Neoadjuvant Chemoradiation for Esophageal CancerZachary D Horne, Rodney E Wegner, Athanasios Colonias, et al.
British Journal of Haematology|February 2, 2022
Association of Rhesus factor blood type with risk of SARS-CoV-2 infection and COVID-19 severityJeffrey L Anderson, Heidi T May, Stacey Knight, et al.
Pageof 50

Showing results (181-190 of 499) with videos related to

Sort By:
Pageof 50
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Hypofractionated stereotactic body radiation therapy for elderly patients with stage IIB-IV nonsmall cell lung cancer who are ineligible for or refuse other treatment modalitiesSana D Karam, Zachary D Horne, Robert L Hong, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Establishing a histology-specific biologically effective dose threshold for lung stereotactic ablative radiotherapy (SABR): Is ≥100 Gy<sub>10</sub> enough?Stephen Abel, Shaakir Hasan, Vivek Verma, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 9, 2020
The Summit Score Stratifies Mortality and Morbidity in Chronic Obstructive Pulmonary DiseaseBenjamin D Horne, Matthew J Hegewald, Courtney Crim, et al.
Journal of Psychosomatic Research|July 14, 2010
Antilipidemic adherence post-coronary artery disease diagnosis among those with and without an ICD-9 diagnosis of depressionHeidi T May, Xiaoming Sheng, A Peter Catinella, et al.
Ecology and Evolution|September 20, 2019
Last exit before the brink: Conservation genomics of the Cambodian population of the critically endangered southern river terrapinF Gözde Çilingir, Adeline Seah, Brian D Horne, et al.
Radiation Oncology (London, England)|July 12, 2013
Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancerSana D Karam, Zachary D Horne, Robert L Hong, et al.
Radiation Oncology Journal|January 12, 2019
Trends in intensity-modulated radiation therapy use for rectal cancer in the neoadjuvant setting: a National Cancer Database analysisRodney E Wegner, Stephen Abel, Richard J White, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
The role of adjuvant therapy for atypical bronchopulmonary carcinoidsRodney E Wegner, Stephen Abel, Shaakir Hasan, et al.
The Annals of Thoracic Surgery|December 18, 2019
Drivers of 30- and 90-day Postoperative Death After Neoadjuvant Chemoradiation for Esophageal CancerZachary D Horne, Rodney E Wegner, Athanasios Colonias, et al.
British Journal of Haematology|February 2, 2022
Association of Rhesus factor blood type with risk of SARS-CoV-2 infection and COVID-19 severityJeffrey L Anderson, Heidi T May, Stacey Knight, et al.
Pageof 50